| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/03/2008 | EP1996624A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 12/03/2008 | EP1996623A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 12/03/2008 | EP1996621A2 Antibodies |
| 12/03/2008 | EP1996620A1 Affinity regions |
| 12/03/2008 | EP1996614A1 Ctsp cancer-testis antigens |
| 12/03/2008 | EP1996231A2 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 12/03/2008 | EP1996230A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 12/03/2008 | EP1996229A1 Intranasal influenza vaccine based on virosomes |
| 12/03/2008 | EP1996228A2 Campylobacter vaccines and methods of use |
| 12/03/2008 | EP1996227A2 Anti-amyloid immunogenic compositions, methods and uses |
| 12/03/2008 | EP1996221A2 Methods for reducing protein aggregation |
| 12/03/2008 | EP1511499B1 Immunomodulatory compounds and methods of use thereof |
| 12/03/2008 | EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide |
| 12/03/2008 | EP1294858B1 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 12/03/2008 | EP1187632B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 12/03/2008 | EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 12/03/2008 | CN101316930A T-cell adhesion molecule and antibody directed against the molecule |
| 12/03/2008 | CN101316927A FcRn受体的用途 FcRn receptor usage |
| 12/03/2008 | CN101316863A Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 12/03/2008 | CN101316626A Methods for reducing blood pressure |
| 12/03/2008 | CN101316612A Stabilization of clostridium botulinum neurotoxin complex |
| 12/03/2008 | CN101316611A Induction of mucosal tolerance to antigens |
| 12/03/2008 | CN101316610A Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 12/03/2008 | CN101316609A Loading of cells with antigens by electroporation |
| 12/03/2008 | CN101316590A Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 12/03/2008 | CN101316588A Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 12/03/2008 | CN101314619A Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof |
| 12/03/2008 | CN101314616A Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 12/03/2008 | CN101314047A Method and medicament for treating viral infection |
| 12/03/2008 | CN101314036A Genetic engineering polypeptide vaccine against livestock foot and mouth disease virus, and preparation method thereof |
| 12/03/2008 | CN101314035A Uses of biological polyoses microcapsule |
| 12/03/2008 | CN100439494C Swine reproduction and respiration syndrome vaccine and its prepn process and application |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439398C Human monoclonal antibodies to dendritic cells |
| 12/03/2008 | CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer |
| 12/03/2008 | CN100439386C Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine |
| 12/03/2008 | CN100438919C Nucleic acid vaccine, and its application |
| 12/03/2008 | CN100438918C Vaccine against SARS virogene and its preparation method and use |
| 12/03/2008 | CN100438908C CpG formulations and related methods |
| 12/03/2008 | CN100438907C Bacterin of tabling gene of E type hepatitis virus |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/02/2008 | US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459538 Recombinant tumor specific antibody and use thereof |
| 12/02/2008 | US7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents |
| 12/02/2008 | US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 12/02/2008 | US7459524 Polypeptide of given sequence; use in vaccines |
| 12/02/2008 | US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders |
| 12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
| 12/02/2008 | US7459291 Chordin-like molecules and uses thereof |
| 12/02/2008 | US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 12/02/2008 | US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 12/02/2008 | US7459172 Drug encapsulation; hollow tubes; drug delivery |
| 12/02/2008 | US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection |
| 12/02/2008 | US7459164 Composition for therapeutic and cosmetic botulinum toxin |
| 12/02/2008 | US7459163 Infectious DNA as a vaccine against west nile and other flaviviruses |
| 12/02/2008 | US7459162 Avian pandemic; immunogens; antibodies; immunology |
| 12/02/2008 | US7459161 Methods for eliciting an immune response using cytolysin and hemolysin fusion proteins |
| 12/02/2008 | US7459160 Chimeric flaviviruses |
| 12/02/2008 | US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens |
| 12/02/2008 | US7459157 Contacting human fluids with antibody directed against Minichromosome Maintenance protein 7 (MCM7 protein) and determining amount of binding; cytology |
| 12/02/2008 | US7459156 Antibodies that mimic actions of neurotrophins |
| 12/02/2008 | US7459154 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 12/02/2008 | US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot |
| 12/02/2008 | CA2269780C Polyanionic polymers as adjuvants for mucosal immunization |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/02/2008 | CA2241918C Peanut allergens and methods |
| 12/02/2008 | CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2 |
| 12/02/2008 | CA2172663C Improved reagents for a cannabinoid immunoassay |
| 12/02/2008 | CA2172507C Methods and compositions for microencapsulation of antigens for use as vaccines |
| 12/02/2008 | CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells |
| 12/02/2008 | CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use |
| 12/01/2008 | CA2589155A1 An attenuated strain of leptospira not expressing the loa22 protein and its use thereof against a leptospiral disease |
| 11/27/2008 | WO2008144753A2 Antibodies to tnf alpha and use thereof |
| 11/27/2008 | WO2008144720A2 Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
| 11/27/2008 | WO2008144659A2 Dickkopf-1 (dkk1) as a universal tumor vaccine for immunotherapy of cancers |
| 11/27/2008 | WO2008144611A2 Il-9 in fibrotic and inflammatory disease |
| 11/27/2008 | WO2008144569A1 Habituation analysis using central nervous system, autonomic nervous system and effector system measurements |
| 11/27/2008 | WO2008144509A1 Method for diagnosis and treatment of pancreatic cancer |
| 11/27/2008 | WO2008144485A2 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity |
| 11/27/2008 | WO2008144484A1 Functional humanization of complementarity determining regions (cdrs) |
| 11/27/2008 | WO2008144067A1 Methods and compositions for treatment of cancer using oncolytic rsv activity |
| 11/27/2008 | WO2008144029A1 Antibody-light fusion products for cancer therapeutics |
| 11/27/2008 | WO2008144019A2 Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
| 11/27/2008 | WO2008143878A1 Methods of reducing eosinophil levels |
| 11/27/2008 | WO2008143717A2 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 11/27/2008 | WO2008143709A2 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 11/27/2008 | WO2008143708A2 Methods and materials related to anti-amyloid antibodies |
| 11/27/2008 | WO2008143705A2 Methods and compositions for rapid inactivation of proteins |
| 11/27/2008 | WO2008143676A1 Detoxified pneumococcal neuraminidase and uses thereof |
| 11/27/2008 | WO2008143665A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 11/27/2008 | WO2008143594A1 Hypoallergenic polypeptides |
| 11/27/2008 | WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 11/27/2008 | WO2008142694A2 Peptides and methods for the treatment of systemic lupus erythematosus |
| 11/27/2008 | WO2008142509A2 Class a oligonucleotides with immunostimulatory potency |
| 11/27/2008 | WO2008142405A1 Method for predicting the response of a patient to treatment with an anti-tnf alpha antibody |
| 11/27/2008 | WO2008142303A2 Use of an anti-cxcr4 antibody for treating cancer |
| 11/27/2008 | WO2008142165A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
| 11/27/2008 | WO2008142157A1 Antibodies useful for therapy and diagnosis of cancer |